DYNE THERAPEUTICS INC shareholders Q3 2021

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MetLife Investment Management, LLC 12,586$204,3970.00%
Nuveen Asset Management, LLC 145,778$2,368,0000.00%
Tower Research Capital LLC (TRC) 1,458$23,0000.00%
FourThought Financial, LLC 671$10,0000.00%
VANGUARD GROUP INC 1,293,342$21,003,0000.00%
Swiss National Bank 51,000$828,0000.00%
Ameritas Investment Partners, Inc. 2,355$38,0000.00%
Point72 Hong Kong Ltd 2,308$37,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 35,183$571,0000.00%
RHUMBLINE ADVISERS 38,390$623,0000.00%
FIRST TRUST ADVISORS LP 34,994$568,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 16,437$267,0000.00%
NORTHERN TRUST CORP 257,212$4,177,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 415,524$6,748,0000.00%
MARSHALL WACE, LLP 22,052$358,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 38,900$632,0000.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 184,183$2,992,0000.00%
BlackRock Inc. 1,988,152$32,288,0000.00%
Bank of New York Mellon Corp 405,262$6,582,0000.00%
Ensign Peak Advisors, Inc 40,000$650,0000.00%
External links

This page lists DYNE THERAPEUTICS INC's shareholders in Q3 2021. To view DYNE THERAPEUTICS INC's shareholder history, click here.